Clinical Trials Logo

Filter by:
NCT ID: NCT04964011 Completed - Clinical trials for Mild Cognitive Impairment

Board Game Intervention to Improve Cognitive and Daily Functioning

Start date: January 3, 2020
Phase: N/A
Study type: Interventional

Background: With the rapid rise of the aging population, the number of seniors with mild cognitive impairment (MCI) has increased, and without timely interventions, participants are at high risk of developing dementia. Board games have become a popular tool for cognitive training, but many board games may not be appropriate for seniors and lack the support of empirical research. Objectives: To examine the effectiveness of a 12-week board game intervention for MCI seniors in improving cognitive functioning and scores on the instrumental activities of daily living (IADL) scale. Methods: A single-blind randomized controlled trial was conducted to collect data from a long-term care facility in central Taiwan. Sixty-eight MCI seniors were recruited and randomized into a board game group (trial group) and a health promotion group (control group). Participants in both groups received a 2-hour intervention once a week for 12 weeks, with the trial group receiving 12 weeks of board games and the control group receiving 12 weeks of health promotion activities. Before and after the intervention, the primary assessment was conducted using the Saint Louis University Mental Status Exam, Contextual Memory Test, and Trail Making Test part-A; the secondary assessment was conducted using the IADL scale.

NCT ID: NCT04958460 Completed - ADHD Clinical Trials

Effect of Probiotics on ADHD

Start date: May 14, 2020
Phase: Phase 3
Study type: Interventional

Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder. Gut microbiome dysbiosis may be associated with the pathophysiology of ADHD. Investigators previously found the relative abundance of Sutterella stercoricanis were increased and Bifidobacterium bifidum were decreased in the ADHD group. Investigators hypothesize that ADHD patients receiving supplementary Bifidobacterium bifidum (Bf-688) is able to increase the proportion of Bf-688; inhibit the proportion of Sutterella; and improve ADHD symptoms.

NCT ID: NCT04952363 Completed - COPD Clinical Trials

Whole-body Vibration on Mucus Clearance, the Quality of Life, and Exercise Capacity for Patients With Chronic Obstructive Pulmonary Disease

Start date: December 22, 2017
Phase: N/A
Study type: Interventional

Although whole body vibration (WBV) is mainly designed to promote neuromuscular function, however, because of its vibration characteristics, whether it can provide additional effects on the sputum clearance for chronic obstructive pulmonary (COPD) disease patients, thereby improving the quality of life, and exercise capacity is still unknown.

NCT ID: NCT04951843 Completed - Sarcopenia Clinical Trials

Koji Product Supplementation' s Study

KPS
Start date: October 12, 2018
Phase: N/A
Study type: Interventional

The present project is to identify the effect of black soy beans Koji product supplementation on nutrients absorption and anti-aging effect in elderly.

NCT ID: NCT04951388 Completed - Covid19 Vaccine Clinical Trials

A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adolescents

Start date: July 22, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and immunogenicity of MVC-COV1901 vaccine compared to placebo in participants aged ≥ 12 to < 18 years.

NCT ID: NCT04949685 Completed - Surgery Clinical Trials

Evaluation of Clinical and Functional Results After Operative Correction of Lesser Toe Deformities

Start date: November 25, 2019
Phase:
Study type: Observational

The plantar plate is an important static stabilizer of lesser metatarsophalangeal joints, and disruptions of the plantar plate can lead to significant instability and lesser toe deformities.Our study proposes an inexpensive and versatile method for plantar plate repair

NCT ID: NCT04948697 Completed - Clinical trials for Advanced Hepatocellular Carcinoma

A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCC

Start date: August 20, 2021
Phase: Phase 2
Study type: Interventional

This is a Phase 2, randomized, multicenter, open-label, 2-arm study to investigate the efficacy and safety of ociperlimab in combination with tislelizumab plus BAT1706, and tislelizumab plus BAT1706, as first-line treatment in participants with advanced HCC.

NCT ID: NCT04945161 Completed - Clinical trials for Diabetic Foot Ulcers

A Randomized,Double-blind,Placebo-controlled Clinical Study to Explore the Mechanism of Action of ON101 Cream in Patients With DFUs.

Start date: February 23, 2021
Phase: N/A
Study type: Interventional

The primary objective is to explore the mechanistic role of ON101 cream in healing diabetic foot ulcers by determining the molecular targets of ON101 cream. Primary endpoint: Percentage change from baseline in the expression level of individual target gene(s) at protein and/or mRNA level. Secondary endpoints: 1. Comparison of the gene and/or protein expression level of individual target between ON101 and Placebo groups 2. Change from baseline in the wound microbiota composition in each group 3. Comparison of the wound microbiota composition between ON101 and Placebo groups 4. Comparison of the wound reduction rate in each group 5. Correlation of wound reduction rate with the alternated level of each target gene in each group. Safety endpoints: Incidence of treatment-emergent adverse event (AE) Change from baseline in vital signs, physical examination, and laboratory tests

NCT ID: NCT04944992 Completed - Clinical trials for Nonalcoholic Steatohepatitis

A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)

Start date: August 4, 2021
Phase: Phase 2
Study type: Interventional

The principal goal of this study is to determine the efficacy of efinopegdutide in liver fat reduction in participants with NAFLD. The primary hypotheses are that efinopegdutide is superior to semaglutide, or that efinopegdutide is superior to semaglutide by at least 10% with respect to mean relative reduction from baseline in liver fat content (LFC) after 24 weeks.

NCT ID: NCT04941677 Completed - Schizophrenia Clinical Trials

Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor Control

Start date: September 17, 2020
Phase:
Study type: Observational [Patient Registry]

The study aims to explore the hand function in people with schizophrenia in the chronic stage.